# Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer

> **NCT00670046** · PHASE2 · TERMINATED · sponsor: **Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins** · enrollment: 15 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** valproic acid
- **OTHER:** standard of care follow-up

## Key facts

- **NCT ID:** NCT00670046
- **Lead sponsor:** Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The study was terminated per the PI decision.
- **Last updated:** 2018-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00670046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00670046, "Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00670046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*